Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending March 9, 2006. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding Ordinary Shares of the Company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory disclosure of share transactions and does not contain financial performance data.
Material Changes
The filing details specific share transfers from the GlaxoSmithKline Employee Trust ("GSK Trust") to participants in the SmithKline Beecham Employee Share Option Plan 1991:
- March 6, 2006: Transfer of 100,021 Ordinary Shares.
- March 7, 2006: Transfer of 262,764 Ordinary Shares.
The Company was advised of these transactions on March 8, 2006. The GSK Trust is a discretionary trust for current and former employees. Three directors (Dr J-P Garnier, Dr T Yamada, and Mr J S Heslop) hold interests in the trust shares similarly to other employees.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the notification of the aforementioned share transactions in accordance with Disclosure Rule 3.1.4R (1) (b).
Investor Verification Points
- Verify the total number of shares transferred (362,785) against the company's employee share plan records.
- Confirm the specific interests of Directors Dr J-P Garnier, Dr T Yamada, and Mr J S Heslop in the GSK Trust.
- Note that this filing does not reflect operational or financial performance for the period.